NDC 67296-1236

REYATAZ

Reyataz

REYATAZ is a Oral Capsule, Gelatin Coated in the Human Prescription Drug category. It is labeled and distributed by Redpharm Drug, Inc.. The primary component is Atazanavir Sulfate.

Product ID67296-1236_4f424439-c80a-22fc-e054-00144ff8d46c
NDC67296-1236
Product TypeHuman Prescription Drug
Proprietary NameREYATAZ
Generic NameReyataz
Dosage FormCapsule, Gelatin Coated
Route of AdministrationORAL
Marketing Start Date2003-06-24
Marketing CategoryNDA / NDA
Application NumberNDA021567
Labeler NameRedPharm Drug, Inc.
Substance NameATAZANAVIR SULFATE
Active Ingredient Strength300 mg/1
Pharm ClassesHIV Protease Inhibitors [MoA],Protease Inhibitor [EPC],UGT1A1 Inhibitors [MoA],UDP Glucuronosyltransferases Inhibitors [MoA],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA],Cytochrome P450 2C8 Inhibitors [MoA]
NDC Exclude FlagE
Listing Certified Through2018-12-31

Packaging

NDC 67296-1236-4

4 CAPSULE, GELATIN COATED in 1 BOTTLE (67296-1236-4)
Marketing Start Date2003-06-24
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 67296-1236-4 [67296123604]

REYATAZ CAPSULE, GELATIN COATED
Marketing CategoryNDA
Application NumberNDA021567
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2003-06-24

Drug Details

Active Ingredients

IngredientStrength
ATAZANAVIR SULFATE300 mg/1

OpenFDA Data

SPL SET ID:4f424439-c809-22fc-e054-00144ff8d46c
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 664741
  • UPC Code
  • 0367296123647
  • Pharmacological Class

    • HIV Protease Inhibitors [MoA]
    • Protease Inhibitor [EPC]
    • UGT1A1 Inhibitors [MoA]
    • UDP Glucuronosyltransferases Inhibitors [MoA]
    • Cytochrome P450 3A4 Inhibitors [MoA]
    • Cytochrome P450 3A Inhibitors [MoA]
    • Cytochrome P450 2C8 Inhibitors [MoA]

    NDC Crossover Matching brand name "REYATAZ" or generic name "Reyataz"

    NDCBrand NameGeneric Name
    0003-3622REYATAZATAZANAVIR
    0003-3624REYATAZATAZANAVIR
    0003-3631REYATAZATAZANAVIR
    0003-3638REYATAZATAZANAVIR
    50090-1007REYATAZATAZANAVIR
    50090-1581REYATAZATAZANAVIR
    67296-1236REYATAZREYATAZ
    69189-3624REYATAZATAZANAVIR
    69189-3631REYATAZATAZANAVIR
    70518-0469REYATAZATAZANAVIR
    70518-0688REYATAZATAZANAVIR
    70518-0725REYATAZATAZANAVIR

    Trademark Results [REYATAZ]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    REYATAZ
    REYATAZ
    78804555 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2006-02-01
    REYATAZ
    REYATAZ
    78169764 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2002-10-01
    REYATAZ
    REYATAZ
    78169761 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2002-10-01
    REYATAZ
    REYATAZ
    78169757 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2002-10-01
    REYATAZ
    REYATAZ
    78169754 not registered Dead/Abandoned
    Bristol-Myers Squibb Company
    2002-10-01
    REYATAZ
    REYATAZ
    78131406 2846482 Live/Registered
    Bristol-Myers Squibb Company
    2002-05-28
    REYATAZ
    REYATAZ
    77829869 4415058 Live/Registered
    Bristol-Myers Squibb Company
    2009-09-18

    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.